VICRA MF 12.5+1000MG (Empagliflozin (12.5mg) + Metformin (1000mg))

VICRA MF 12.5+1000MG is a medication commonly used to help manage blood sugar levels in adults with type 2 diabetes. It supports patients by working to improve how the body processes glucose, which can be an essential part of overall diabetes care. Regular use, along with a balanced diet and exercise, may contribute to better glycemic control.

The active ingredients in this medication are Empagliflozin and Metformin. Empagliflozin helps the kidneys remove excess sugar from the bloodstream through urine, while Metformin improves insulin sensitivity and reduces glucose production in the liver. Together, they aim to help maintain more stable blood sugar levels over time.

For optimal effectiveness, it is important to store the tablets in a cool, dry place, away from direct sunlight and out of reach of children. Consistency in taking the medication as directed is essential for achieving the best results. Patients should be aware of their overall health and any changes that may occur during treatment, and communicate with their healthcare provider about these.

Some common, mild side effects may include nausea, stomach upset, or increased urination. These effects are typically temporary, but if they persist or worsen, it is advisable to seek medical guidance.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.